N-Methyl-DL-valine (hydrochloride)

CAT:
804-HY-W142140A-01
Size:
50 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
N-Methyl-DL-valine (hydrochloride) - image 1

N-Methyl-DL-valine (hydrochloride)

  • UNSPSC Description:

    N-Methyl-DL-valine (N-Methylvaline) hydrochloride is a valine derivant, is metabolized to cysteine, alanine, tyrosine, tryptophan, citric acid, and succinic acid in the sprout. N-Methyl-DL-valine hydrochloride involves in the modification of monomethyl auristatin F (MMAF), an anti-tubulin agent, makes it hydrophobic functionalization and increases cell permeability[1][2].
  • Target Antigen:

    Others
  • Type:

    Reference compound
  • Related Pathways:

    Others
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/n-methyl-dl-valine-hydrochloride.html
  • Purity:

    98.0
  • Solubility:

    DMSO : 125 mg/mL (ultrasonic)
  • Smiles:

    O=C(C(C(C)C)NC)O.[H]Cl
  • Molecular Weight:

    167.63
  • References & Citations:

    [1]M. Pasteels, et al. Uptake and metabolism of [14C]rinderine and [14C]retronecine in leaf-beetles of the genus Platyphora and alkaloid accumulation in the exocrine defensive secretions. Chemoecology. 2003;13:55–62.|[2]Philip N Moquist, et al. Novel Auristatins with High Bystander and Cytotoxic Activities in Drug Efflux–positive Tumor Models. Mol Cancer Ther.2021;20(2): 320–328.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -20°C (Powder, sealed storage, away from moisture)
  • Clinical Information:

    No Development Reported